Skip to main content
SpringerLink
Log in

Pathological predictors for lymph node metastasis in T1 colorectal cancer

  • Original Article
  • Published:
Surgery Today Aims and scope Submit manuscript

Abstract

Purpose

To clarify pathological predictor for lymph node metastasis in T1 colorectal cancer.

Methods

One hundred and sixty-four patients who underwent surgery for single T1 colorectal cancer were reviewed. The pathological differentiations of non-well differentiation, invasion depth (≥2 000 μm), lymphatic channel involvement, venous invasion, and tumor budding were selected as candidate predictors. Tumor budding was estimated according to the definition proposed by Ueno et al. (Gastroenterology 2004; 127:385–394). The lymph node status was set for the endpoint. Logistic regression model was applied to analyze the predictors.

Results

Lymph node involvement was observed in 9.8%. The positive rates were 13.4% for the pathological differentiations of non-well differentiation, 51.8% for invasion depth (≥2 000 μm), 6.1% for lymphatic channel involvement, 8.5% for venous invasion, and 14.6% for tumor budding. The pathological differentiations of non-well differentiation (P < 0.001) and tumor budding (P = 0.002) were significantly associated with lymph node metastasis in multivariate analysis. When either two significant factors was adopted for the prediction of the lymph node metastasis, the sensitivity, specificity, positive predictive value, and negative predictive value were 94%, 82%, 36%, and 99%, respectively.

Conclusion

The pathological differentiations of non-well differentiation and tumor budding are useful predictors for lymph node metastasis in T1 colorectal cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Kikuchi R, Takano M, Takagi K, Fujimoto N, Nozaki R, Fujiyoshi T, et al. Management of early invasive colorectal cancer. Risk of recurrence and clinical guidelines. Dis Colon Rectum 1995;38:1286–1295.

    Article  PubMed  CAS  Google Scholar 

  2. Tanaka S, Haruma K, Teixeira CR, Tatsuta S, Ohtsu N, Hiraga Y, et al. Endoscopic treatment of submucosal invasive colorectal carcinoma with special reference to risk factors for lymph node metastasis. J Gastroenterol 1995;30:710–717.

    Article  PubMed  CAS  Google Scholar 

  3. Nascimbeni R, Burgart LJ, Nivatvongs S, Larson DR. Risk of lymph node metastasis in T1 carcinoma of the colon and rectum. Dis Colon Rectum 2002;45:200–206.

    Article  PubMed  Google Scholar 

  4. Sakuragi M, Togashi K, Konishi F, Koinuma K, Kawamura Y, Okada M, et al. Predictive factors for lymph node metastasis in T1 stage colorectal carcinomas. Dis Colon Rectum 2003;46: 1626–1632.

    Article  PubMed  Google Scholar 

  5. Shimomura T, Ishiguro S, Konishi H, Wakabayashi N, Mitsufuji S, Kasugai T, et al. New indication for endoscopic treatment of colorectal carcinoma with submucosal invasion. J Gastroenterol Hepatol 2004;19:48–55.

    Article  PubMed  Google Scholar 

  6. Kitajima K, Fujimori T, Fujii S, Takeda J, Ohkura Y, Kawamata H, et al. Correlations between lymph node metastasis and depth of submucosal invasion in submucosal invasive colorectal carcinoma: a Japanese collaborative study. J Gastroenterol 2004;39:534–543.

    Article  PubMed  Google Scholar 

  7. Wang HS, Liang WY, Lin TC, Chen WS, Jiang JK, Yang SH, et al. Curative resection of T1 colorectal carcinoma: risk of lymph node metastasis and long-term prognosis. Dis Colon Rectum 2005;48:1182–1192.

    Article  PubMed  Google Scholar 

  8. Richards WO, Webb WA, Morris SJ, Davis RC, McDaniel L, Jones L, et al. Patient management after endoscopic removal of the cancerous colon adenoma. Ann Surg 1987;205:665–672.

    Article  PubMed  CAS  Google Scholar 

  9. Volk EE, Goldblum JR, Petras RE, Carey WD, Fazio VW. Management and outcome of patients with invasive carcinoma arising in colorectal polyps. Gastroenterology 1995;109:1801–1807.

    Article  PubMed  CAS  Google Scholar 

  10. Cranley JP, Petras RE, Carey WD, Paradis K, Sivak MV. When is endoscopic polypectomy adequate therapy for colonic polyps containing invasive carcinoma? Gastroenterology 1986;91:419–427.

    PubMed  CAS  Google Scholar 

  11. Cooper HS, Deppisch LM, Gourley WK, Kahn EI, Lev R, Manley PN, et al. Endoscopically removed malignant colorectal polyps: clinicopathologic correlations. Gastroenterology 1995;108: 1657–1665.

    Article  PubMed  CAS  Google Scholar 

  12. Netzer P, Forster C, Biral R, Ruchti C, Neuweiler J, Stauffer E, et al. Risk factor assessment of endoscopically removed malignant colorectal polyps. Gut 1998;43:669–674.

    Article  PubMed  CAS  Google Scholar 

  13. Kyzer S, Begin LR, Gordon PH, Mitmaker B. The care of patients with colorectal polyps that contain invasive adenocarcinoma. Endoscopic polypectomy or colectomy? Cancer 1992;70: 2044–2050.

    Article  PubMed  CAS  Google Scholar 

  14. Schlemper RJ, Riddell RH, Kato Y, Borchard F, Cooper HS, Dawsey SM, et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut 2000;47:251–255.

    Article  PubMed  CAS  Google Scholar 

  15. Morodomi T, Isomoto H, Shirouzu K, Kakegawa K, Irie K, Morimatsu M. An index for estimating the probability of lymph node metastasis in rectal cancers. Lymph node metastasis and the histopathology of actively invasive regions of cancer. Cancer 1989;63:539–543.

    Article  PubMed  CAS  Google Scholar 

  16. Hase K, Shatney C, Johnson D, Trollope M, Vierra M. Prognostic value of tumor “budding” in patients with colorectal cancer. Dis Colon Rectum 1993;36(7):627–635

    Article  PubMed  CAS  Google Scholar 

  17. Prall F, Nizze H, Barten M. Tumour budding as prognostic factor in stage I/II colorectal carcinoma. Histopathology 2005;47:17–24.

    Article  PubMed  CAS  Google Scholar 

  18. Goldstein NS, Hart J. Histologic features associated with lymph node metastasis in stage T1 and superficial T2 rectal adenocarcinomas in abdominoperineal resection specimens. Identifying a subset of patients for whom treatment with adjuvant therapy or completion abdominoperineal resection should be considered after local excision. Am J Clin Pathol 1999;111:51–58.

    PubMed  CAS  Google Scholar 

  19. Hase K, Shatney CH, Mochizuki H, Johnson DL, Tamakuma S, Vierra M, et al. Long-term results of curative resection of “minimally invasive” colorectal cancer. Dis Colon Rectum 1995;38: 19–26

    Article  PubMed  CAS  Google Scholar 

  20. Masaki T, Matsuoka H, Sugiyama M, Abe N, Mori T, Atomi Y, et al. Budding as a useful determinant of the optimal treatment for T1 rectal carcinomas. Hepatogastroenterology 2003;50:388–391.

    PubMed  Google Scholar 

  21. Masaki T, Sugiyama M, Matsuoka H, Abe N, Izumisato Y, Goto A, et al. Clinical utility of grading criteria for submucosal invasion in the prognosis of T1 colorectal carcinomas. J Gastroenterol 2003;38:37–44.

    Article  PubMed  Google Scholar 

  22. Ueno H, Murphy J, Jass JR, Mochizuki H, Talbot IC. Tumour “budding” as an index to estimate the potential of aggressiveness in rectal cancer. Histopathology 2002;40:127–132

    Article  PubMed  CAS  Google Scholar 

  23. Ueno H, Mochizuki H, Hashiguchi Y, Shimazaki H, Aida S, Hase K, et al. Risk factors for an adverse outcome in early invasive colorectal carcinoma. Gastroenterology 2004;127:385–394.

    Article  PubMed  Google Scholar 

  24. Japanese Research Society for Cancer of the Colon and Rectum. General rules for clinical and pathological studies on cancer of the colon, rectum and anus. Part I. Clinical classification. Jpn J Surg 1983;13:557–573.

    Article  Google Scholar 

  25. Muto T, Nishizawa M, Kodaira S. Risk factors of lymph node metastasis of colorectal submucosal carcinoma: A quantitative analysis of 857 cases (in Japanese with English abstract). Stomach Intestine 1991;26:911–918.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Saitama Medical Center, Jichi Medical University, Saitama, Japan

    Hitoshi Yamauchi, Yutaka J. Kawamura, Junichi Sasaki, Shingo Tsujinaka & Fumio Konishi

  2. Department of Surgery, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke, Tochigi, 329-0498, Japan

    Kazutomo Togashi, Hisanaga Horie & Yoshikazu Yasuda

Authors
  1. Hitoshi Yamauchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kazutomo Togashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yutaka J. Kawamura
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hisanaga Horie
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Junichi Sasaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Shingo Tsujinaka
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yoshikazu Yasuda
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Fumio Konishi
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

This paper was presented at the Annual Meeting of the American Gastroenterology Association held in Los Angeles, CA, USA on May 23, 2006.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yamauchi, H., Togashi, K., Kawamura, Y.J. et al. Pathological predictors for lymph node metastasis in T1 colorectal cancer. Surg Today 38, 905–910 (2008). https://doi.org/10.1007/s00595-007-3751-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00595-007-3751-x

Key words

Search

Navigation